These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37220609)

  • 1. Alternate Donor Transplantation.
    Hwang WY; Kongtim P; Majhail NS; Yao M
    Blood Cell Ther; 2022 Dec; 5(Spec Edition):S6-S14. PubMed ID: 37220609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes of Unrelated Umbilical Cord Blood Graft vs. Haploidentical Donor Transplantation: Critical Issues for an Adequate Comparison.
    Vanegas D; Niño-Quiroga L; Chaparro M; Camacho-Rodríguez B; Estupiñán M; Perdomo-Arciniegas AM
    Front Med (Lausanne); 2021; 8():749810. PubMed ID: 34778312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.
    Murata M; Takenaka K; Uchida N; Ozawa Y; Ohashi K; Kim SW; Ikegame K; Kanda Y; Kobayashi H; Ishikawa J; Ago H; Hirokawa M; Fukuda T; Atsuta Y; Kondo T
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1536-1543. PubMed ID: 30826464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
    Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
    Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HLA in cord blood transplantation outcomes.
    Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
    HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies.
    Fabricius WA; Ramanathan M
    Adv Hematol; 2016; 2016():5726132. PubMed ID: 27034676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
    Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.
    Symons HJ; Leffell MS; Rossiter ND; Zahurak M; Jones RJ; Fuchs EJ
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):533-42. PubMed ID: 19961944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting the best haploidentical donor.
    McCurdy SR; Fuchs EJ
    Semin Hematol; 2016 Oct; 53(4):246-251. PubMed ID: 27788762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis.
    Yanada M; Konuma T; Yamasaki S; Harada K; Iwasaki M; Kobayashi A; Nishijima A; Tanaka M; Uchida N; Nakamae H; Fukuda T; Onizuka M; Ozawa Y; Sawa M; Katayama Y; Yoshioka S; Kimura T; Ichinohe T; Atsuta Y; Kanda J; Yano S
    Transplant Cell Ther; 2021 Dec; 27(12):1005.e1-1005.e8. PubMed ID: 34500125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haploidentical hematopoietic stem cell transplant: How to choose the best donor? Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Dubois V; Amokrane K; Beguin Y; Bruno B; Chevallier P; Delbos F; Devillier R; Giannoli C; Guidicelli G; Harif M; Loiseau P; Rouzaire PO; Varlet P; Yakoub-Agha I; Nguyen S
    Bull Cancer; 2020 Jan; 107(1S):S72-S84. PubMed ID: 31586527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allogeneic hematopoietic stem cell transplantation for hematological malignancies: an algorithm for donor selection].
    Sugita J
    Rinsho Ketsueki; 2019; 60(6):626-634. PubMed ID: 31281155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies in haploidentical stem cell transplantation in adults.
    Bayraktar UD; Ciurea SO
    Turk J Haematol; 2013 Dec; 30(4):342-50. PubMed ID: 24385823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables.
    Solomon SR; Aubrey MT; Zhang X; Piluso A; Freed BM; Brown S; Jackson KC; Morris LE; Holland HK; Solh MM; Bashey A
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):789-798. PubMed ID: 29355721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes from unrelated donor hematopoietic stem cell transplantation.
    Perez LE
    Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection.
    Mehta RS
    Clin Lymphoma Myeloma Leuk; 2024 May; ():. PubMed ID: 38825445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.
    Tsai SB; Liu H; Shore T; Fan Y; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Martinez G; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS
    Biol Blood Marrow Transplant; 2016 Jun; 22(6):1065-1072. PubMed ID: 26912055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
    Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
    Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.